Longevity Biotech, Timeline, Leads the Way in Healthy Aging Research with Groundbreaking Clinical Studies

LAUSANNE, Switzerland--(BUSINESS WIRE)--Regulatory News: Timeline®, a pioneering Swiss consumer biotech company at the forefront of longevity research, is proud to announce the successful completion of its landmark immune aging clinical study, MitoImmune, using Mitopure (proprietary Urolithin A). Additionally, the company has partnered on two new clinical trials in collaboration with prestigious research institutions to expand its applications of Mitopure for healthy aging. Timeline, backed by